Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV

Clinical trial NCT06135350 · RECRUITING

Trial details

NCT number: NCT06135350
Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gram Negative Pneumonia Gram-Negative Bacterial Infections Bacteremia Caused by Gram-Negative Bacteria

Start date: 2023-11-06
Primary completion: 2025-12-31
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.